Clinical Trial Update: Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence trial comparing Norditropin and Genotropin somatropin in healthy adult volunteers has completed, assessing pharmacokinetic/pharmacodyna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Disorders
• Idiopathic Short Stature
• Prader-willi Syndrome

Drugs mentioned

• GENOTROPIN (SOMATROPIN)
• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Prader-Willi Syndrome | Phase 1 | Status: COMPLETED